» Articles » PMID: 17275978

N-Acetylaspartate in the CNS: from Neurodiagnostics to Neurobiology

Overview
Journal Prog Neurobiol
Specialty Neurology
Date 2007 Feb 6
PMID 17275978
Citations 609
Authors
Affiliations
Soon will be listed here.
Abstract

The brain is unique among organs in many respects, including its mechanisms of lipid synthesis and energy production. The nervous system-specific metabolite N-acetylaspartate (NAA), which is synthesized from aspartate and acetyl-coenzyme A in neurons, appears to be a key link in these distinct biochemical features of CNS metabolism. During early postnatal central nervous system (CNS) development, the expression of lipogenic enzymes in oligodendrocytes, including the NAA-degrading enzyme aspartoacylase (ASPA), is increased along with increased NAA production in neurons. NAA is transported from neurons to the cytoplasm of oligodendrocytes, where ASPA cleaves the acetate moiety for use in fatty acid and steroid synthesis. The fatty acids and steroids produced then go on to be used as building blocks for myelin lipid synthesis. Mutations in the gene for ASPA result in the fatal leukodystrophy Canavan disease, for which there is currently no effective treatment. Once postnatal myelination is completed, NAA may continue to be involved in myelin lipid turnover in adults, but it also appears to adopt other roles, including a bioenergetic role in neuronal mitochondria. NAA and ATP metabolism appear to be linked indirectly, whereby acetylation of aspartate may facilitate its removal from neuronal mitochondria, thus favoring conversion of glutamate to alpha ketoglutarate which can enter the tricarboxylic acid cycle for energy production. In its role as a mechanism for enhancing mitochondrial energy production from glutamate, NAA is in a key position to act as a magnetic resonance spectroscopy marker for neuronal health, viability and number. Evidence suggests that NAA is a direct precursor for the enzymatic synthesis of the neuron specific dipeptide N-acetylaspartylglutamate, the most concentrated neuropeptide in the human brain. Other proposed roles for NAA include neuronal osmoregulation and axon-glial signaling. We propose that NAA may also be involved in brain nitrogen balance. Further research will be required to more fully understand the biochemical functions served by NAA in CNS development and activity, and additional functions are likely to be discovered.

Citing Articles

Non-targeted Metabolomics Reveals the Potential Role of MFSD8 in Metabolism in Human Endothelial Cells.

Xiang Q, Chen Y, Cheng X, Fang X, Liu Y, Huang Y Mol Biotechnol. 2025; .

PMID: 39992484 DOI: 10.1007/s12033-025-01396-7.


ATP-sensitive potassium channels alter glycolytic flux to modulate cortical activity and sleep.

Constantino N, Carroll C, Williams H, Vekaria H, Yuede C, Saito K Proc Natl Acad Sci U S A. 2025; 122(8):e2416578122.

PMID: 39964713 PMC: 11874466. DOI: 10.1073/pnas.2416578122.


Glutamate/GABA/glutamine ratios in intact and ischemia reperfusion challenged rat brain subregions, the effect of ischemic preconditioning.

Baranovicova E, Kalenska D, Lehotsky J Metab Brain Dis. 2025; 40(2):121.

PMID: 39918622 PMC: 11805880. DOI: 10.1007/s11011-024-01511-8.


"Advances in biomarker discovery and diagnostics for alzheimer's disease".

Bhatia V, Chandel A, Minhas Y, Kushawaha S Neurol Sci. 2025; .

PMID: 39893357 DOI: 10.1007/s10072-025-08023-y.


[Analysis of ischemic stroke biomarkers based on non-targeted metabolomics].

Xu F, Liu T, Guan Y, Hao W, Wen D, Xie S Se Pu. 2025; 43(2):139-147.

PMID: 39844704 PMC: 11758226. DOI: 10.3724/SP.J.1123.2024.02015.


References
1.
Fenstermacher M, Narayana P . Serial proton magnetic resonance spectroscopy of ischemic brain injury in humans. Invest Radiol. 1990; 25(9):1034-9. DOI: 10.1097/00004424-199009000-00016. View

2.
Hagenfeldt L, Bollgren I, Venizelos N . N-acetylaspartic aciduria due to aspartoacylase deficiency--a new aetiology of childhood leukodystrophy. J Inherit Metab Dis. 1987; 10(2):135-41. DOI: 10.1007/BF01800038. View

3.
Fulham M, Bizzi A, Dietz M, Shih H, Raman R, Sobering G . Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology. 1992; 185(3):675-86. DOI: 10.1148/radiology.185.3.1438744. View

4.
Bruhn H, Frahm J, Merboldt K, Hanicke W, Hanefeld F, Christen H . Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol. 1992; 32(2):140-50. DOI: 10.1002/ana.410320205. View

5.
Namboodiri A, Moffett J, Arun P, Mathew R, Namboodiri S, Potti A . Defective myelin lipid synthesis as a pathogenic mechanism of Canavan disease. Adv Exp Med Biol. 2006; 576:145-63. DOI: 10.1007/0-387-30172-0_10. View